Drugs target to SMN2

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophy, type IISurvival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneDistal hereditary motor neuropathy type 1Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator2.0CompletedClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophySurvival motor neuron protein positive modulator1.0CompletedClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophySurvival motor neuron protein positive modulator3.0CompletedClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophy with respiratory distress type 2Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
NUSINERSEN SODIUMOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator4.0-FDA
RISDIPLAMSmall moleculespinal muscular atrophySMN2 pre-mRNA positive modulator4.0RecruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator2.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneSpinal muscular atrophy with respiratory distress type 1Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator3.0Enrolling by invitationClinicalTrials
ONASEMNOGENE ABEPARVOVECGenedistal hereditary motor neuropathy type 2Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGenedistal spinal muscular atrophy type 3Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator2.0TerminatedClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator3.0Active, not recruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator2.0RecruitingClinicalTrials
RISDIPLAMSmall moleculespinal muscular atrophySMN2 pre-mRNA positive modulator2.0RecruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator1.0CompletedClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneProximal spinal muscular atrophy type 3Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator3.0RecruitingClinicalTrials
RISDIPLAMSmall moleculeAtrophySMN2 pre-mRNA positive modulator4.0-DailyMed
RISDIPLAMSmall moleculespinal muscular atrophySMN2 pre-mRNA positive modulator2.0Active, not recruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator3.0TerminatedClinicalTrials
RISDIPLAMSmall moleculespinal muscular atrophySMN2 pre-mRNA positive modulator4.0-FDA
ONASEMNOGENE ABEPARVOVECGeneX-linked distal arthrogryposis multiplex congenitaSurvival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophySurvival motor neuron protein positive modulator3.0Not yet recruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator4.0RecruitingClinicalTrials
NUSINERSENOligonucleotidespinal muscular atrophySMN2 pre-mRNA positive modulator3.0CompletedClinicalTrials
RISDIPLAMSmall moleculespinal muscular atrophySMN2 pre-mRNA positive modulator4.0Not yet recruitingClinicalTrials
ONASEMNOGENE ABEPARVOVECGeneProximal spinal muscular atrophy type 2Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
RISDIPLAMSmall moleculespinal muscular atrophySMN2 pre-mRNA positive modulator1.0CompletedClinicalTrials
ONASEMNOGENE ABEPARVOVECGenespinal muscular atrophy, type 1Survival motor neuron protein positive modulator3.0Active, not recruitingClinicalTrials
RISDIPLAMSmall moleculespinal muscular atrophySMN2 pre-mRNA positive modulator1.0RecruitingClinicalTrials